TipRanks
Actinogen Medical Limited (DE:3AC)
FRANKFURT:3AC

Compare Actinogen Medical (3AC) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Actinogen Medical
€0.02
€129.94M
-11.25
171.43%
1 Buy
0 Hold
0 Sell
Moderate Buy
Tryptamine Therapeutics
AU$0.04
AU$63.71M
-16.52
-4.76%
―
Neuren Pharmaceuticals Limited
AU$20.45
AU$2.57B
129.34
-4.98%
5 Buy
0 Hold
0 Sell
Strong Buy
Alterity Therapeutics
AU$0.51
AU$87.08M
-3.44
-26.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Zelira Therapeutics
AU$0.50
AU$5.95M
-1.56
31.58%
―
Neuroscientific Biopharmaceuticals Ltd.
AU$0.06
AU$22.60M
-4.17
-60.65%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:3AC
Actinogen Medical
0.04
0.02
153.33%
AU:ENP
Tryptamine Therapeutics
0.04
>-0.01
-2.44%
AU:NEU
Neuren Pharmaceuticals Limited
20.43
-0.87
-4.10%
AU:ATH
Alterity Therapeutics
0.37
-0.18
-32.73%
AU:ZLD
Zelira Therapeutics
0.50
0.12
31.58%
AU:NSB
Neuroscientific Biopharmaceuticals Ltd.
0.06
-0.10
-61.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts